Drug Shortage Report for VITAMIN B12
Report ID | 238955 |
Drug Identification Number | 00521515 |
Brand name | VITAMIN B12 |
Common or Proper name | VITAMIN B12 |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | VITAMIN B12 |
Strength(s) | 1000MCG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR |
Packaging size | 10ML |
ATC code | B03BA |
ATC description | VITAMIN B12 AND FOLIC ACID |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-09-30 |
Estimated end date | 2024-10-04 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-10-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-10-01 | English | Compare |
v3 | 2024-09-30 | French | Compare |
v2 | 2024-09-30 | English | Compare |
v1 | 2024-09-30 | English | Compare |
Showing 1 to 4 of 4